B-Cell Lymphoma Lesions Show Homogeneous Enhancement with Gadolinium on MRI
B-cell lymphoma lesions characteristically demonstrate homogeneous, moderate-to-strong enhancement after gadolinium administration on MRI scans 1, 2.
Enhancement Pattern Characteristics
The typical MRI appearance of B-cell lymphoma lesions includes:
- Homogeneous enhancement: The lesions enhance uniformly throughout after gadolinium administration 3, 4, 5
- Moderate enhancement intensity: Not as intense as some other tumors, but clearly visible 5
- T1-weighted imaging: Intermediate to slightly high signal intensity
- T2-weighted imaging: Slightly high signal intensity
- Post-gadolinium T1: Moderately enhanced appearance 5
Site-Specific Enhancement Patterns
Primary CNS Lymphoma (Brain Parenchyma)
Gadolinium-enhanced MRI is the most relevant tool for defining disease extension in the brain and spinal cord 1. Brain lesions typically show strong, homogeneous enhancement that reflects the highly proliferative nature of these tumors (often >90% Ki-67 expression) 1.
Bing-Neel Syndrome (CNS Involvement in Waldenström Macroglobulinemia)
Two distinct enhancement patterns exist after gadolinium administration 2:
- Diffuse form: Enhancement or thickening of the meningeal sheath due to leptomeningeal and perivascular infiltration
- Tumoral form: Unifocal or multifocal mass lesions with enhancement
Optic Nerve/Chiasm Involvement
When B-cell lymphoma involves the anterior visual pathway, MRI reveals fusiform enlargement with homogeneous enhancement of the affected nerve structures 3, 4.
Peripheral Nerve Involvement
Cranial or peripheral nerve lymphoma presents as nerve swelling with gadolinium enhancement 6.
Dynamic Enhancement Characteristics
When dynamic contrast-enhanced MRI is performed, B-cell lymphomas demonstrate a characteristic temporal pattern 5:
- Rapid initial increase in contrast enhancement
- Peak enhancement at 45-120 seconds
- Relatively rapid washout in most cases (82.4%)
- A minority (17.6%) show plateau maintenance followed by gradual decrease
Clinical Pitfall
Critical timing consideration: Because of the extremely high proliferative activity of primary CNS lymphoma, brain MRI should be repeated after biopsy and ideally within 14 days before starting treatment, as tumor growth can be rapid enough to affect therapeutic response assessment 1.
The homogeneous enhancement pattern, while relatively characteristic, is not entirely specific for lymphoma and must be interpreted in the appropriate clinical context with histopathological confirmation 5.